Oceania Healthcare (NZSE:OCA) First Half 2025 Results

Key Financial Results

• Revenue: NZ$133.5m (up 1.4% from 1H 2024).
• Net loss: NZ$17.1m (down by 149% from NZ$35.2m profit in 1H 2024).
• NZ$0.024 loss per share (down from NZ$0.049 profit in 1H 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Oceania Healthcare Earnings Insights

Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Healthcare industry in New Zealand.

Performance of the New Zealander Healthcare industry.

The company's shares are down 2.6% from a week ago.

Risk Analysis

Be aware that Oceania Healthcare is showing 2 warning signs in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.